1d
GlobalData on MSNBoehringer Ingelheim and Salipro enter drug discovery partnershipThe partnership brings together Salipro’s tech for stabilising drug targets from Boehringer’s drug discovery programmes.
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable ...
Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...
Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that the ongoing ion channel research collaboration with Boehringer Ingelheim has been extended with one year. "The p ...
February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the ...
Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...
The first-ever mixnet VPN will debut at event featuring Nym's in-house security expert Chelsea Manning. NymVPN is a groundbreaking decentralized Virtual Private Network (dVPN) that protects users from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results